Bryan Kestenbaum
Director, SoM MedSci, Epidemiology and Biostatistics Course · University of Washington School of Medicine
Credentials: · · · · ·
History
1996–1998- 1995–1998
Internal Medicine
Research
Kidney disease and increased mortality risk in type 2 diabetes
Journal of the American Society of Nephrology · 2013 · 1,029 citations
Serum phosphate levels and mortality risk among people with chronic kidney disease
Journal of the American Society of Nephrology · 2005 · First of 8 authors · Corresponding · 917 citations
Effects of phosphate binders in moderate CKD
Journal of the American Society of Nephrology · 2012 · 405 citations
176 papers · 19 as a resident
89 papers
65 papers
62 papers
60 papers
49 papers
40 papers
- SS
33 papers · 1 as a fellow
Grants
- 2026–2030
Early Ultrafiltration for Patients Initiating Hemodialysis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $773.9K · University of Washington
- 2024–2029
Northwest Comprehensive Research Training in Kidney, Urologic, and Hematologic Sciences (NCOR-KUH)
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
PI · $1.1M · University of Washington
- 2022–2026
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.5M · Vanderbilt University Medical Center
- 2020–2025
Kidney Tubular Functions in Type 1 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.7M · University of Washington
Clinical trials
- 2026–2030
Dry Weight Reduction Intervention Via Extra Ultrafiltration
Principal investigator · Not yet recruiting
University of Washington
- 2018–2021
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease
Principal investigator · Completed · Phase 2
University of Washington
- 2017–2022
Individualized Response to Vitamin D Treatment Study
Principal investigator · Completed
University of Washington